HCA Health Inc vs Zscaler Inc — how do they compare? HCA Health Inc trades at $451.09 (market cap $96.35B), while Zscaler Inc trades at $233.73 (market cap $35.35B). The key difference: HCA Health Inc is far larger — about 2.7× Zscaler Inc's market cap, and HCA Health Inc pays a 0.7% dividend while Zscaler Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Zscaler Inc for 41 Days on average.
| HCA | ZS | |
|---|---|---|
Market Cap | $96.35B | $35.35B |
Volume | 1,079,453 | 3,726,203 |
Sector | Health | Technology |
52-Week High | $545.13 | $336.27 |
52-Week Low | $361.32 | $118.05 |
Typical Hold Time | 76 Days | 41 Days |
Enterprise Value | $146.88B | $33.73B |
Dividend Yield | 0.7% | — |
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $445.01, up 1.33% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.60 billion in 2025, with net income of $6.78 billion, while valuation metrics like a P/E of 14.92 appear reasonable. The company announced a dividend of $0.78 and completed the acquisition of The College of Health Care Professions, signaling growth initiatives.
The outlook is positive, supported by analyst consensus with a $461.12 price target and 63% buy ratings, though risks include ongoing legal investigations and high debt levels. Earnings growth and operational efficiency remain key drivers for potential upside, but investors should monitor regulatory and competitive pressures.
Zscaler (ZS) trades at $216.99, up 1.61% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $1.1B in 2022 to $2.67B in 2025, though remains unprofitable with a -1.88% net margin. Recent quarters have consistently beaten EPS expectations, and analyst sentiment remains overwhelmingly positive with 79.63% buy ratings. Key developments include AI-related bookings growth and upcoming Investor Day on October 6, 2026.
ZS presents a growth-focused opportunity with expanding cybersecurity demand and AI integration, but carries execution risks from recent executive turnover and competitive pressures. The stock trades near consensus price targets with potential upside to $298, though high valuation multiples and ongoing losses require careful monitoring of profitability improvements.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →Zscaler is a security-as-a-service firm that offers its customers cloud-delivered solutions for protecting user devices and data. The firm leverages its position in 150 colocation data centers to deliver traditionally appliance-based security functionality, such as firewalls and sandboxes, as a completely cloud-native platform. The firm focuses on large enterprise customers and offers two primary product suites: Zscaler Internet Access, which securely connects users to externally managed application and websites (such as Salesforce and Google), and Zscaler Private Access, which securely connects users to internally managed applications. Both product suites encompass a broad gamut of capabilities situated across the traditional security stack.
Read more on ZS →